AARTIPHARMNSEAarti Pharmalabs LimitedMediumNeutral
Announced Tue, 26 May · 22:17 IST

Aarti Pharmalabs Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.9%1-day move
₹694.65
prior close
₹694.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-1.1-0.8-1.3-6.9-7.6-8.4-10.5-7.6-12.5-5.1-2.4-1.7
Up moveDown movePending
AI summary

Aarti Pharmalabs Limited has informed exchanges that the audio recording of its Q4 FY26 earnings conference call has been uploaded to the company website. The call covered audited financial results for Q4 and full year ended March 31, 2026. The recording can be accessed at the company's website. This filing is made under SEBI (LODR) Regulation 30. The company previously notified about this call on May 20, 2026. This is a standard regulatory disclosure providing public access to the earnings call discussion.

Likely market impact

This is a routine compliance filing with no new information or financial guidance. It simply makes an existing earnings call recording publicly accessible, which is positive for investor transparency but has no direct impact on stock price or shareholder value.